Chandan Healthcare Ltd
Incorporated in September 2003, Chandan Healthcare Limited runs diagnostic centers in North India with pathology and radiology testing services.[1]
- Market Cap ₹ 634 Cr.
- Current Price ₹ 259
- High / Low ₹ 358 / 150
- Stock P/E 23.4
- Book Value ₹ 55.3
- Dividend Yield 0.00 %
- ROCE 28.4 %
- ROE 25.8 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 71.0% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 29.4%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Working capital days have increased from 9.16 days to 108 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Part of Nifty SME Emerge
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 67 | 56 | 72 | 76 | 100 | 129 | |
| 60 | 51 | 69 | 67 | 74 | 92 | |
| Operating Profit | 6 | 5 | 3 | 9 | 25 | 37 |
| OPM % | 9% | 9% | 4% | 12% | 25% | 29% |
| 0 | 0 | 0 | 0 | 1 | 1 | |
| Interest | 2 | 2 | 2 | 2 | 2 | 4 |
| Depreciation | 2 | 2 | 2 | 2 | 3 | 6 |
| Profit before tax | 2 | 1 | -1 | 5 | 21 | 28 |
| Tax % | 39% | 45% | 93% | 23% | 24% | 26% |
| 1 | 1 | -1 | 4 | 16 | 21 | |
| EPS in Rs | 0.71 | 0.41 | -0.68 | 2.02 | 8.01 | 8.50 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 14% |
| 3 Years: | 22% |
| TTM: | 26% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 71% |
| 3 Years: | 154% |
| TTM: | 39% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 28% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 21% |
| 3 Years: | 29% |
| Last Year: | 26% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 20 | 20 | 20 | 20 | 20 | 24 | 24 |
| Reserves | 4 | 5 | 3 | 7 | 21 | 96 | 111 |
| 15 | 14 | 15 | 17 | 29 | 33 | 51 | |
| 20 | 18 | 22 | 26 | 23 | 23 | 23 | |
| Total Liabilities | 59 | 56 | 59 | 70 | 93 | 177 | 209 |
| 20 | 20 | 25 | 28 | 44 | 71 | 86 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 4 | 5 |
| Investments | 20 | 11 | 14 | 15 | 13 | 10 | 49 |
| 19 | 25 | 21 | 27 | 37 | 91 | 70 | |
| Total Assets | 59 | 56 | 59 | 70 | 93 | 177 | 209 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| -7 | 7 | 5 | 6 | -19 | ||
| 7 | -10 | -2 | -15 | -36 | ||
| -0 | -2 | -2 | 9 | 60 | ||
| Net Cash Flow | 0 | -4 | 1 | -1 | 6 | |
| Free Cash Flow | -7 | 1 | -0 | -13 | -57 | |
| CFO/OP | -121% | 274% | 61% | 37% | -31% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Debtor Days | 54 | 76 | 53 | 77 | 80 | 88 |
| Inventory Days | 88 | 78 | 37 | 9 | ||
| Days Payable | 126 | 224 | 233 | 399 | ||
| Cash Conversion Cycle | 15 | -69 | -143 | -314 | 80 | 88 |
| Working Capital Days | -66 | -10 | -60 | -67 | -14 | 108 |
| ROCE % | 9% | 2% | 18% | 41% | 28% |
Insights
In beta| Mar 2023 | Mar 2024 | Sep 2025 | |
|---|---|---|---|
| Geographic Presence (States) Number |
|
||
| Number of Diagnostic Centres Number |
|||
| Total Patient Count Lakhs |
|||
| Total Tests Conducted Lakhs |
|||
| Number of Collection Centres Number |
|||
| Number of Pharmacy Stores Number |
|||
| Pathology Tests Offered Number |
|||
| Radiology Tests Offered Number |
|||
| Revenue per patient INR |
|||
Extracted by Screener AI
Documents
Announcements
-
Disclosure of material issue
2 April 2026 - Chandan Healthcare acquired Nishkam Imaging in Yamuna Vihar, New Delhi, to expand diagnostic services.
-
General Updates
27 March 2026 - Launched Raipur diagnostic centre (Mar 27, 2026) offering pathology, TMT, ECG, PFT; entry into Chhattisgarh.
-
Trading Window
26 March 2026 - Trading window closed Apr 1, 2026 until 48 hours after results for quarter/FY ending Mar 31, 2026.
-
General Updates
24 March 2026 - Won 10-year tender to install 1.5T MRI at Civil Hospital, Rohtak (200-bed, ~40,000 monthly OPD).
-
General Updates
20 March 2026 - Won 10-year tender to install 1.5T MRI at Civil Hospital, Rohtak (awarded 20-Mar-2026).
Concalls
-
Feb 2026Transcript PPT
-
Dec 2025Transcript PPT
-
Nov 2025TranscriptAI SummaryPPT REC
-
Aug 2025TranscriptAI SummaryPPT
Business Profile[1]
Chandan Healthcare Limited operates a diagnostic network in North India that offers pathology and radiology testing services. The company has a presence in Uttar Pradesh, Uttarakhand, and Jaipur (Rajasthan), with a strong network of labs, satellite centers, and collection points